PWP
IRWD icon

Private Wealth Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Private Wealth Partners’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-66,864
Closed -$889K – 116
2016
Q3 		$889K Hold
66,864
– – 0.21% 64
2016
Q2 		$732K Buy
+66,864
New +$653K 0.18% 75

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Private Wealth Partners's IRWD Position: Q4 2017 in Review

Private Wealth Partners sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2017, closing a stake of 13,588 shares — an estimated $179K sold.

Private Wealth Partners first reported a position in IRWD in Q1 2014 and held it in 15 quarters. The position peaked at $1.79M in Q4 2014. 158 funds tracked by Wall St. Rank hold IRWD as of Q4 2017.

  • Private Wealth Partners reported no remaining Ironwood Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Private Wealth Partners sold 13,588 Ironwood Pharmaceuticals shares in Q4 2017, an estimated $179K.
  • Private Wealth Partners first reported a position in Ironwood Pharmaceuticals in Q1 2014 and held it in 15 quarters.
  • Private Wealth Partners's Ironwood Pharmaceuticals position peaked at $1.79M in Q4 2014.
  • 158 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2017.

Based on Private Wealth Partners's 13F filing for Q4 2017, filed 1 Feb 2018.